EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
25 04-2022

Visit the extended exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU”

2022-04-25T08:32:05+00:0025-04-2022|News|

On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition "Living with MS during COVID-19: A case for rethinking MS care in the EU" brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level. Impact of the COVID-19 pandemic on multiple sclerosis at [...]

28 10-2021

Registration open for “Best practices for patient safety: An EU-wide view on the use of medicines off-label” event on 30 November 2021

2021-10-28T09:59:06+00:0028-10-2021|News|

The European Brain Council is pleased to invite you to register for the digital event "Best practices for patient safety: An EU-wide view on the use of medicines off-label" to be held virtually on 30 November 2021 at 14:30 - 16:00 CET. In 2016, the Declaration for Good Off-Label Use Practice was launched, supported by a [...]

27 05-2021

EBC launches “RETHINKING MS in times of COVID-19” on the occasion of World Multiple Sclerosis Day

2021-06-28T07:51:36+00:0027-05-2021|News|

On the occasion of the approaching World Multiple Sclerosis Day (30 May 2021), the European Brain Council is excited to announce the release of its new policy paper, "RETHINKING MS in times of COVID-19". This new paper is part of the main report "RETHINKING MS in Europe", a research-driven project offering tangible policy changes [...]

25 05-2021

Registration open for “Patient safety and informed consent: The importance of good off-label use practices” event on 17 June 2021

2021-05-25T11:13:44+00:0025-05-2021|News|

The European Brain Council is pleased to invite you to register for the digital event "Patient safety and informed consent: The importance of good off-label use practices" to be held virtually on 17 June 2021 at 14:30 - 16:00CET. The event is co-organised with EUCOPE. In 2016, the Declaration for Good Off-Label Use Practice was launched, supported [...]

7 03-2021

Last week to register for the MULTI-ACT Project’s Final Conference

2021-03-16T14:26:25+00:0007-03-2021|News|

After years of work, the outcomes of the MULTI-ACT project will be presented at the Final Conference, “The MULTI-ACT model: the path forward for participatory governance in health research and innovation”, to be held virtually on 23 March 2021 at 14:00-17:00. The EU-funded MULTI-ACT project aims to increase the impact of health research on [...]

24 02-2021

What can we learn from the vaccination campaign?

2021-02-24T11:37:34+00:0024-02-2021|News|

Just over a month ago, EBC published its statement on the impact of COVID-19 on brain health, hoping that the growing evidence of the long-term effects of the disease would be taken into account in the planning for post-pandemic recovery at the EU and national levels. It continues to grow more evident that COVID-19 has [...]

18 02-2021

MULTI-ACT project launches Save the Date for Final Conference

2021-02-23T12:30:23+00:0018-02-2021|News|

MULTI-ACT Final Conference The MULTI-ACT Model: The Path Forward for Participatory Governance in Health Research and Innovation 23 March 2021 (14:00-17:00 CET) After years of work, the outcomes of the MULTI-ACT project will be presented at the Final Conference, “The MULTI-ACT model: the path forward for participatory governance in health research and innovation”, to be held [...]

28 01-2021

Event report: Virtual workshop on the off-label use of medicines in Sweden and Norway

2021-02-18T13:43:47+00:0028-01-2021|News|

Striking the right balance between timely access to medicines and maintaining the highest standards of patient safety. Introduction to the event The event, hosted by the Swedish Brain Foundation, the Norwegian MS Association and the European Brain Council was held virtually on 24 November 2020. It brought together over 80 representatives from Norway and [...]

28 01-2021

EU-Funded BRAINTEASER project, bringing AI home for better care of ALS and MS, kicks off!

2022-04-14T12:42:44+00:0028-01-2021|News|

Officially started on the 1st of January 2021, the H2020 BRAINTEASER project kicked off its operational activities on 28 and 29 January, at the presence of its project officer Mr Tobias Wiesenthal, Head of Sector 'Research and Innovation' at DG CONNECT.H.3 – eHealth, Well-Being and Ageing. All the 11 partners, a multidisciplinary gender-balanced consortium [...]

Go to Top